唐人神(002567.SZ)擬投資2.4億元建成年產36萬噸高科技生物飼料項目
格隆匯4月26日丨唐人神(002567.SZ)公佈,公司於2020年4月24日召開第八屆董事會第十七次會議,審議通過了《關於簽署<項目投資合同書>的議案》,同意公司與天水市武山縣人民政府簽署《項目投資合同書》。公司計劃投資總額2.4億元人民幣,建成年產36萬噸高科技生物飼料生產項目。
項目用地位於武山縣工業園區內。約100畝,具體面積、位置以最終土地招拍掛出讓地紅線圖為準,土地性質為工業用地。
根據公司發展規劃,為公司甘肅100萬頭生豬養殖基地提供飼料,同時,對外銷售,輻射西北區域,增強公司飼料產業實力。該項目的建設,是公司實施生豬養殖產業發展戰略,保證公司養豬場的用料安全及營養供應,增強公司飼料盈利能力,實現公司可持續發展的重要戰略佈局,經濟效益良好,同時能有效帶動周邊地區就業,具有良好的社會效益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.